NaSal increased the excitability of 5-HTergic neurons, but decreased that of GABAergic neurons in the DRN of the ChR2 transgenic mouse. by Yan Jin (143500)

“…(E) Sample recordings from a GABAergic neuron showing that NaSal decreased voltage responses to a series of hyperpolarizing currents (-10 to -60 pA, -10 pA/step, duration: 500 ms). …”

Results for fibrin dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Results for RBC dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Result of different feature selection methods: (a) feature selection results based on MIC; (b) feature selection results based on RFECV; (c) feature selection results based on MDA. by Zhen Zhao (159931)

Identification of <i>T. gondii</i> Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion by Jacqueline M. Leung (120235)

“…Finally, a knock-in parasite line expressing the C58S mutation showed decreased sensitivity to compound treatment in a quantitative 3D motility assay. …”

Figure 3 from TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma by Jessica D. Daley (22128489)

2OAA decreases LPS-induced COX2 protein levels in differentiated human U937 cells challenged with LPS. by Daniel H. Lopez (450866)

Supplemental Figure 4: UAB30 decreased migration. from Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies by Alicia M. Waters (9314636)

“…Both cell lines showed a significant decrease in the ability to migrate following UAB30. …”

Net effects of increased PKD activities above basal levels are loss of barbed end formation and decreased directed cell migration. by Heike Döppler (105264)

Ursolic Acid Increases Skeletal Muscle and Brown Fat and Decreases Diet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease by Steven D. Kunkel (156806)

“…Consistent with increased skeletal muscle and brown fat, ursolic acid increased energy expenditure, leading to reduced obesity, improved glucose tolerance and decreased hepatic steatosis. These data support a model in which ursolic acid reduces obesity, glucose intolerance and fatty liver disease by increasing skeletal muscle and brown fat, and suggest ursolic acid as a potential therapeutic approach for obesity and obesity-related illness.…”

R1R2 decreases CXCR4⁺ cell accumulation in the bleomycin-induced fibrotic lung tissues. by Hou-Yu Chiang (691992)

Individuals with Type 1 and Type 2 Diabetes Mellitus Trade Increased Hyperglycemia for Decreased Hypoglycemia When Glycemic Variability is not Improved by Sujit R. Jangam (4863304)

Overexpression of MeCP2 decreases new branch formation in developing tectal neurons but does not interfere with the stability of existing branches. by Sonya Marshak (329939)

ACP-GAG binding promotes GBS invasion into fly heads; glial GAG polymerase knock-down decreases lethal infection. by Yung-Chi Chang (216307)

Image_6_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)

Image_1_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)

Image_4_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)

Image_1_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)

Image_2_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)

Image_3_Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination.tiff by Lydia Horndler (10503959)